Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "MUC5"
Filter
Filter
Article category
Keywords
Publication year
Authors
Case Report
Primary Mucinous Cystadenocarcinoma of the Breast: Cytologic Finding and Expression of MUC5 Are Different from Mucinous Carcinoma
Sung Eun Kim, Ji Hye Park, SoonWon Hong, Ja Seung Koo, Joon Jeong, Woo-Hee Jung
Korean J Pathol. 2012;46(6):611-616.   Published online December 26, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.6.611
  • 7,689 View
  • 57 Download
  • 13 Crossref
AbstractAbstract PDF

Mucinous cystadenocarcinoma (MCA) in the breast is a rare neoplasm. There have been 13 cases of primary breast MCA reported. The MCA presents as a large, partially cystic mass in postmenopausal woman with a good prognosis. The microscopic findings resemble those of ovarian, pancreatic, or appendiceal MCA. The aspiration findings showed mucin-containing cell clusters in the background of mucin and necrotic material. The cell clusters had intracytoplasmic mucin displacing atypical nuclei to the periphery. Histologically, the tumor revealed an abundant mucin pool with small floating clusters of mucin-containing tumor cells. There were also small cysts lined by a single layer of tall columnar mucinous cells, resembling those of the uterine endocervix. The cancer cells were positive for mucin (MUC) 5 and negative for MUC2 and MUC6. This mucin profile is different from ordinary mucinous carcinoma and may be a unique characteristic of breast MCA.

Citations

Citations to this article as recorded by  
  • Mucinous cystadenocarcinoma of the breast harbours TRPS1 expressions and PIK3CA alterations
    Wei‐Yu Chen, Yu‐Hsuan Hu, Yu‐Hsin Tsai, Jen‐Fan Hang, Puay Hoon Tan, Chih‐Jung Chen
    Histopathology.2024; 84(3): 550.     CrossRef
  • Pure mucinous adenocarcinoma of the breast with the rare lymphoplasmacytic infiltration: A case report with review of literature
    Yash Hasmukhbhai Prajapati, Vishal Bhabhor, Kahan Samirkumar Mehta, Mithoon Barot, Husen Boriwala, Mohamed Omar
    Clinical Case Reports.2024;[Epub]     CrossRef
  • HER2‐positive mucinous cystadenocarcinoma of the breast coexisting with invasive lobular carcinoma: A case report and review of the literature
    Ismail Guzelis, Betul Bolat Kucukzeybek, Mehmet Ali Uyaroglu, Melek Bekler Gokova, Gulten Sezgin, Yuksel Kucukzeybek
    Diagnostic Cytopathology.2024;[Epub]     CrossRef
  • Mammary mucinous cystadenocarcinoma with long-term follow-up: molecular information and literature review
    Ting Lei, Yong Qiang Shi, Tong Bing Chen
    Diagnostic Pathology.2023;[Epub]     CrossRef
  • Primary Mucinous Cystadenocarcinoma of the Breast Intermixed with Pleomorphic Invasive Lobular Carcinoma: The First Report of This Rare Association
    Federica Vegni, Nicoletta D’Alessandris, Angela Santoro, Giuseppe Angelico, Giulia Scaglione, Angela Carlino, Damiano Arciuolo, Michele Valente, Stefania Sfregola, Maria Natale, Alejandro Martin Sanchez, Valeria Masciullo, Gian Franco Zannoni, Antonino Mu
    Journal of Personalized Medicine.2023; 13(6): 948.     CrossRef
  • Special Histologic Type and Rare Breast Tumors – Diagnostic Review and Clinico-Pathological Implications
    Benjamin Yongcheng Tan, Elaine Hsuen Lim, Puay Hoon Tan
    Surgical Pathology Clinics.2022; 15(1): 29.     CrossRef
  • Mucinous cystadenocarcinoma of the breast: a new entity with broad differentials—a case report
    Kanwalpreet Kaur, Ashini Shah, Jahnvi Gandhi, Priti Trivedi
    Journal of the Egyptian National Cancer Institute.2022;[Epub]     CrossRef
  • Mucinous carcinoma of the breast: distinctive histopathologic and genetic characteristics
    Minjung Jung
    Kosin Medical Journal.2022; 37(3): 176.     CrossRef
  • Primary Mucinous Cystadenocarcinoma of the Breast: A Rare Case Report With Review of Literature
    Ekta Jain, Abhishek Kumar, Raajul Jain, Shivani Sharma
    International Journal of Surgical Pathology.2021; 29(7): 740.     CrossRef
  • Mucinous Cystadenocarcinoma of the Breast: Report of 2 Cases Including One With Long-Term Local Recurrence
    Anupma Nayak, Ira J. Bleiweiss, Kimberly Dumoff, Tawfiqul A. Bhuiya
    International Journal of Surgical Pathology.2018; 26(8): 749.     CrossRef
  • Mucinous breast carcinoma with tall columnar cells
    N Tsoukalas, M Kiakou, M Tolia, ID Kostakis, M Galanopoulos, G Nakos, D Tryfonopoulos, G Kyrgias, G Koumakis
    The Annals of The Royal College of Surgeons of England.2018; 100(5): e132.     CrossRef
  • Radiologic Findings of Primary Mucinous Cystadenocarcinoma of the Breast: A Report of Two Cases and a Literature Review
    Minjung Seong, Eun Young Ko, Boo-Kyung Han, Soo Youn Cho, Eun Yoon Cho, Se Kyung Lee, Jeong Eon Lee
    Journal of Breast Cancer.2016; 19(3): 330.     CrossRef
  • Primary Mucinous Cystadenocarcinoma of the Breast with Endocervical-Like Mucinous Epithelium
    Dong-Liang Lin, Ji-Lin Hu, Shi-Hong Shao, Dong-Mei Sun, Ji-Gang Wang
    Breast Care.2013; 8(6): 445.     CrossRef
Original Article
Expression Patterns of Tumor Related Proteins for Differential Diagnoses of Intrahepatic Adenocarcinomas.
Ghil Suk Yoon, Mi Sung Kim, Young Hwa Li, Ji Hyun Uhm, Sun Ju Kim, Tae Sook Kim, In Su Suh, Han Ik Bae
Korean J Pathol. 2005;39(4):229-235.
  • 1,679 View
  • 15 Download
AbstractAbstract PDF
Background
: Differential diagnoses of intrahepatic adenocarcinomas (IHAC) play an important role in the detecting primary sites and the determining type of treatment and overall prognosis of the patient. However, histopathologic findings alone have limitations of differential diagnoses of IHAC. Methods : To clarify which tumor related proteins (TRP) are useful for differential diagnoses of IHAC, TRP expression were investigated immunohistochemically, using MUC5AC, MUC2, mAb 91.9H, MUC1, and pS2, and by high iron diamine (HID) staining in 61 clinically confirmed IHACs. Results : MUC5AC (9/18, p<0.05) and MUC1 (17/18, p>0.05) displayed the most frequent expression in cholangiocarcinomas, and MUC2 (11/18, p<0.05), mAb 91.9H (16/18, p<0.05), and HID (16/18, p<0.05) in colorectal adenocarcinomas. pS2 (3/11, p>0.05) was expressed more often in pancreatic adenocarcinomas than other IHAC, while MUC2 and 91.9H were not expressed at all in pancreatic adenocarcinomas. The positivity of several TRP did not correlate with tumor differentiation. Conclusions : MUC5AC, MUC2, mAb 91.9H, and HID may be useful in differentiating cholangiocarcinomas from colorectal adenocarcinomas.

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP